Results 11 to 20 of about 195 (85)

Combined Pulmonary Fibrosis and Emphysema Syndrome Complicated by Lung Cancer

Southern Clinics of Istanbul Eurasia, 2018
Combined pulmonary fibrosis and emphysema syndrome (CPFE) is a rare disease characterized by emphysema in the upper lobes of the lung and fibrosis in the lower lobes. CPFE is an important risk factor for lung cancer (LC). Although CPFE might increase the
Nesrin Kıral Gürbüz, Saadet Akkuş, Banu Salepçi, Sevda Şener Cömert, Elif Torun Parmaksız, Coşkun Doğan   +5 more
doaj   +1 more source

The value of CT for disease detection and prognosis determination in combined pulmonary fibrosis and emphysema (CPFE). [PDF]

PLoS ONE, 2014
BACKGROUND AND PURPOSE: Several imaging-based indices were constructed quantitatively using the emphysema index (EI) and fibrosis score (FS) on high-resolution computed tomography (HRCT).
Seung Hee Choi, Ho Yun Lee, Kyung Soo Lee, Man Pyo Chung, O Jung Kwon, Joungho Han, Namkug Kim, Joon Beom Seo   +7 more
doaj   +1 more source

Adenosine and hyaluronan promote lung fibrosis and pulmonary hypertension in combined pulmonary fibrosis and emphysema

Disease Models & Mechanisms, 2019
Combined pulmonary fibrosis and emphysema (CPFE) is a syndrome that predominantly affects male smokers or ex-smokers and it has a mortality rate of 55% and a median survival of 5 years.
Scott D. Collum, Jose G. Molina, Ankit Hanmandlu, Weizhen Bi, Mesias Pedroza, Tinne C. J. Mertens, Nancy Wareing, Wang Wei, Cory Wilson, Wenchao Sun, Jayakumar Rajadas, Paul L. Bollyky, Kemly M. Philip, Dewei Ren, Rajarajan A. Thandavarayan, Brian A. Bruckner, Yang Xia, Michael R. Blackburn, Harry Karmouty-Quintana   +18 more
doaj   +1 more source

Prognosis of patients with acute exacerbation of combined pulmonary fibrosis and emphysema: a retrospective single-centre study

BMC Pulmonary Medicine, 2020
Background Previous analyses of combined pulmonary fibrosis and emphysema (CPFE) cohorts have provided conflicting data on the survival of patients with CPFE.
Yuichi Ikuyama, Atsuhito Ushiki, Makoto Kosaka, Jumpei Akahane, Yuichi Mukai, Taisuke Araki, Yoshiaki Kitaguchi, Kazunari Tateishi, Kazuhisa Urushihata, Masanori Yasuo, Hiroshi Yamamoto, Masayuki Hanaoka   +11 more
doaj   +1 more source

Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation

BMC Pulmonary Medicine, 2019
Background In non-small cell lung cancer (NSCLC) patients, concomitant idiopathic pulmonary fibrosis (IPF) and emphysema (CPFE) are independently related to poor survival. CPFE is a condition with features of both pulmonary fibrosis and emphysema.
Sung Woo Moon, Moo Suk Park, Young Sam Kim, Joon Jang, Jae Ho Lee, Choon-Taek Lee, Jin-Haeng Chung, Hyo Sup Shim, Kyung Won Lee, Seung-Seob Kim, Sang Hoon Lee, Ho Il Yoon   +11 more
doaj   +1 more source

Lung Cancer in Combined Pulmonary Fibrosis and Emphysema: A Systematic Review and Meta-Analysis.

PLoS ONE, 2016
PurposePatients with combined pulmonary fibrosis and emphysema (CPFE) have been suggested to have an increased risk of lung cancer. We conducted a systematic review of all published data and performed a meta-analysis to define the characteristics of lung
Hyun Jung Koo, Kyung-Hyun Do, Jung Bok Lee, Sania Alblushi, Sang Min Lee   +4 more
doaj   +1 more source

Association of combined pulmonary fibrosis and emphysema in rheumatoid arthritis with high titer of rheumatoid factor and autoimmunity to the lung

Frontiers in Immunology
BackgroundCombined pulmonary fibrosis and emphysema (CPFE) commonly coexists with connective tissue diseases (CTD), such as rheumatoid arthritis (RA). However, the risk factors contributing to the development of CTD-CPFE remain largely unidentified. This
Aiping Ma, Renliang Huang, Jiaxi Guo, Guangdong Wang, Heqing Huang, Xinze Li, Shan Zhong, Yan Huang, Shaowei Lin, Yikai Lin, Qiaomiao Zhou, Susanne Krauss-Etschmann, Frank Petersen, Zhanxiang Wang, Xinhua Yu, Xinhua Yu   +15 more
doaj   +1 more source

Tolerability and effectiveness of definitive chemoradiotherapy in locally advanced lung cancer patients with combined pulmonary fibrosis and emphysema

Cancer Treatment and Research Communications
Background: This study evaluated the efficacy and safety of definitive chemoradiotherapy (CRT) for lung cancer in patients with combined pulmonary fibrosis and emphysema (CPFE), focusing on radiation pneumonitis (RP).
Kana Fujimoto, Mariko Kogo, Hisato Kobayashi, Masakazu Ogura, Tomohiro Ozaki, Hirofumi Kiyokawa, Daisuke Natori, Hitoomi Okamori, Kenta Nishi, Hideki Yamanaka, Daisuke Iwashima, Kenichi Takahashi   +11 more
doaj   +1 more source

A Borane Sandwich Analogue of Ferrocene

Angewandte Chemie, Volume 138, Issue 29, 13 July 2026.
The first ferrocene analogue with two boron‐based ligands is identified through a global exploration of the FeB10H20 potential energy surface. The η5,η5‐Fe(B5H10)2 complex emerges as the global minimum, showing that metal coordination inverts borane stability and enables aromatic boron rings inaccessible in isolation.
Viviana Roman‐Ventura, Luis Quispe‐Corimayhua, Dumer S. Sacanamboy, Diego Inostroza, Luis Leyva‐Parra, Dayán Páez, Kelling J. Donald, Gabriel Merino, William Tiznado   +8 more
wiley   +2 more sources

Lung cancer and combined pulmonary fibrosis and emphysema with anti-ARS antibody

Romanian Journal of Internal Medicine, 2022
A 59-year-old man who had smoked for 23 pack-years was admitted to our hospital because of two-month history of back pain. The chest computed tomography scan demonstrated combined pulmonary fibrosis and emphysema (CPFE) and an irregular shaped nodule in ...
Tanimura Riho, Nishino Kengo, Iwade Ryosuke, Abe Ryo, Okauchi Shinichiro, Sasatani Yuika, Satoh Hiroaki   +6 more
doaj   +1 more source